AVITA Medical, Inc.
ASX:AVH.AX
2.88 (AUD) • At close May 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 21.226 | 17.646 | 10.55 | 9.455 | 14.215 | 12.072 | 10.074 | 9.546 | 7.02 | 10.304 | 11.539 | 6.619 | 7.068 | 5.618 | 6.304 | 4.645 | 4.815 |
| Cost of Revenue
| 3.287 | 3.309 | 2.493 | 1.979 | 2.392 | 2.007 | 2.376 | 1.124 | 1.088 | 2.053 | 2.825 | 1.065 | 1.298 | 1.266 | 1.031 | 1.206 | 0.917 |
| Gross Profit
| 17.939 | 14.337 | 13.287 | 11.91 | 11.823 | 10.065 | 7.698 | 8.422 | 5.932 | 8.251 | 8.714 | 5.554 | 5.77 | 4.351 | 5.273 | 3.439 | 3.898 |
| Gross Profit Ratio
| 0.845 | 0.812 | 1.259 | 1.26 | 0.832 | 0.834 | 0.764 | 0.882 | 0.845 | 0.801 | 0.755 | 0.839 | 0.816 | 0.775 | 0.836 | 0.74 | 0.81 |
| Reseach & Development Expenses
| 6.835 | 7.621 | 6.86 | 4.963 | 5.94 | 4.431 | 4.837 | 5.778 | 3.388 | 3.974 | 5.409 | 4.359 | 4.713 | 3.678 | 4.057 | 3.295 | 2.422 |
| General & Administrative Expenses
| 9.396 | 8.935 | 12.092 | 7.816 | 7.824 | 7.624 | 9.791 | 7.564 | 5.349 | 5.275 | 6.877 | 4.157 | 11.335 | 13.797 | 20.489 | 9.582 | 4.273 |
| Selling & Marketing Expenses
| 16.384 | 15.019 | 9.783 | 9.316 | 8.46 | 7.723 | 6.452 | 6.818 | 3.518 | 4.146 | 4.804 | 4.669 | 4.561 | 6.173 | 7.114 | 5.661 | 4.388 |
| SG&A
| 25.779 | 24.269 | 22.19 | 17.132 | 16.284 | 15.647 | 16.519 | 14.532 | 8.867 | 9.421 | 11.942 | 9.08 | 16.157 | 20.241 | 27.907 | 15.79 | 9.934 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.016 | 0.002 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 31.459 | 29.897 | 27.028 | 19.729 | 20.544 | 19.122 | 20.326 | 20.054 | 11.881 | 12.955 | 16.592 | 12.852 | 20.032 | 23.046 | 29.735 | 18.394 | 9.165 |
| Operating Income
| -14.346 | -16.757 | -14.825 | -8.678 | -8.987 | -9.215 | -12.677 | -11.605 | -5.949 | -4.704 | -7.887 | -7.303 | -14.267 | -18.87 | -25.052 | -15.096 | -5.42 |
| Operating Income Ratio
| -0.676 | -0.95 | -1.405 | -0.918 | -0.632 | -0.763 | -1.258 | -1.216 | -0.847 | -0.457 | -0.684 | -1.103 | -2.019 | -3.359 | -3.974 | -3.25 | -1.126 |
| Total Other Income Expenses Net
| 0.81 | 1.186 | 1.078 | 0.85 | 0.256 | 0.152 | 0.037 | -0.039 | 0.016 | 0.002 | 0.005 | 0.001 | -0.004 | 0.164 | 0.582 | 0.128 | 0.136 |
| Income Before Tax
| -13.535 | -15.571 | -13.746 | -7.828 | -8.731 | -9.063 | -12.64 | -11.643 | -5.942 | -4.711 | -7.882 | -7.302 | -14.271 | -18.707 | -24.47 | -14.967 | -5.283 |
| Income Before Tax Ratio
| -0.638 | -0.882 | -1.303 | -0.828 | -0.614 | -0.751 | -1.255 | -1.22 | -0.846 | -0.457 | -0.683 | -1.103 | -2.019 | -3.33 | -3.881 | -3.222 | -1.097 |
| Income Tax Expense
| 0.017 | 0.02 | 0.045 | 0.035 | 0.006 | 0.006 | 0.005 | 0.026 | 0.006 | 0.007 | 0.013 | 0.014 | 0.014 | 0.006 | 0 | 0 | 0 |
| Net Income
| -13.552 | -15.591 | -13.791 | -7.863 | -8.737 | -9.068 | -12.645 | -11.67 | -5.948 | -4.718 | -7.895 | -7.316 | -14.285 | -18.712 | -24.47 | -14.967 | -5.283 |
| Net Income Ratio
| -0.638 | -0.884 | -1.307 | -0.832 | -0.615 | -0.751 | -1.255 | -1.222 | -0.847 | -0.458 | -0.684 | -1.105 | -2.021 | -3.331 | -3.881 | -3.222 | -1.097 |
| EPS
| -0.106 | -0.124 | -0.11 | -0.062 | -0.07 | -0.072 | -0.102 | -0.094 | -0.048 | -0.038 | -0.07 | -0.068 | -0.132 | -0.176 | -0.23 | -0.15 | -0.056 |
| EPS Diluted
| -0.106 | -0.124 | -0.11 | -0.062 | -0.07 | -0.072 | -0.102 | -0.094 | -0.048 | -0.038 | -0.07 | -0.068 | -0.134 | -0.176 | -0.23 | -0.152 | -0.056 |
| EBITDA
| -14.091 | -16.538 | -14.623 | -8.487 | -8.771 | -9.016 | -12.46 | -11.39 | -5.933 | -4.702 | -7.667 | -7.093 | -13.972 | -18.566 | -24.904 | -14.956 | -5.322 |
| EBITDA Ratio
| -0.664 | -0.937 | -1.386 | -0.898 | -0.617 | -0.747 | -1.237 | -1.193 | -0.845 | -0.456 | -0.664 | -1.072 | -1.977 | -3.305 | -3.95 | -3.22 | -1.105 |